1. Home
  2. LGVN vs PT Comparison

LGVN vs PT Comparison

Compare LGVN & PT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • PT
  • Stock Information
  • Founded
  • LGVN 2014
  • PT 2012
  • Country
  • LGVN United States
  • PT China
  • Employees
  • LGVN N/A
  • PT N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • PT Computer Software: Programming Data Processing
  • Sector
  • LGVN Health Care
  • PT Technology
  • Exchange
  • LGVN Nasdaq
  • PT Nasdaq
  • Market Cap
  • LGVN 16.4M
  • PT 14.7M
  • IPO Year
  • LGVN 2021
  • PT 2018
  • Fundamental
  • Price
  • LGVN $0.89
  • PT $0.86
  • Analyst Decision
  • LGVN Strong Buy
  • PT
  • Analyst Count
  • LGVN 2
  • PT 0
  • Target Price
  • LGVN $6.50
  • PT N/A
  • AVG Volume (30 Days)
  • LGVN 399.0K
  • PT 207.2K
  • Earning Date
  • LGVN 11-11-2025
  • PT 09-19-2025
  • Dividend Yield
  • LGVN N/A
  • PT N/A
  • EPS Growth
  • LGVN N/A
  • PT N/A
  • EPS
  • LGVN N/A
  • PT N/A
  • Revenue
  • LGVN $2,073,000.00
  • PT $4,961,892.00
  • Revenue This Year
  • LGVN N/A
  • PT N/A
  • Revenue Next Year
  • LGVN N/A
  • PT N/A
  • P/E Ratio
  • LGVN N/A
  • PT N/A
  • Revenue Growth
  • LGVN 68.67
  • PT 9.20
  • 52 Week Low
  • LGVN $0.63
  • PT $0.76
  • 52 Week High
  • LGVN $2.48
  • PT $1.38
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 48.25
  • PT 32.98
  • Support Level
  • LGVN $0.73
  • PT $0.88
  • Resistance Level
  • LGVN $0.82
  • PT $0.95
  • Average True Range (ATR)
  • LGVN 0.03
  • PT 0.07
  • MACD
  • LGVN 0.02
  • PT -0.02
  • Stochastic Oscillator
  • LGVN 94.35
  • PT 4.21

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

Share on Social Networks: